By Elizabeth Svoboda Updated December 8, 2022, 3:00 a.m.
New apps promise to detect when you’re feeling blue and o!er some
assistance. But they still have to prove that the benefits of sharing
sensitive data outweigh any drawbacks.
Read MoreBy Elizabeth Svoboda Updated December 8, 2022, 3:00 a.m.
New apps promise to detect when you’re feeling blue and o!er some
assistance. But they still have to prove that the benefits of sharing
sensitive data outweigh any drawbacks.
Read MoreSonde Health raised $19.25 million in Series B funding to globalize its voice-based disease screening technology with partners in Korea and India. CEO David Liu tells Axios exclusively.
Read MoreSEOUL -- South Korea's top telecom company KT will enhance the competitiveness of the artificial intelligence-based health diagnosis business through a strategic investment in Sonde Health, a United States-based digital medicine company specializing in the detection of various diseases such as mental health and respiratory disorders through the analysis of voices.
Read MoreSoftware that analyzes snippets of your speech to identify mental health problems is rapidly making its way into call centers, medical clinics and telehealth platforms. The idea is to detect illnesses that might otherwise go untreated. Why it matters: Proponents of "voice biomarker" technology say the underlying artificial intelligence is good enough to recognize depression, anxiety and a host of other maladies.
Read MoreSonde Health, a leading enterprise vocal biomarker company, today announced that it has integrated the M3 Checklist into its Mental Fitness application programming interface (API), giving Sonde customers’ users access to a multi-conditional assessment tool that measures symptoms for major depression, bipolar disorder, anxiety disorder, and post-traumatic stress disorder (PTSD).
Read MoreSonde Health, a leading enterprise vocal biomarker company, has signed a multi-year agreement with Koye Pharmaceuticals, a specialty pharma organization focused on the Indian Pharmaceutical market, to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease (COPD) in India. This deal represents Sonde’s first partnership with a pharmaceutical company.
Read MoreDavid Liu is CEO of Sonde Health, a company using vocal biomarkers to assess patient health, wellness, and fitness. The company is white labeling its solution for app developers with initial products for respiratory and mental health problems.
In the interview, Liu discusses the product, technology, and key markets serving as the first adopters. These include healthcare providers and payers along with one industry I wasn’t expecting.
Liu has been CEO of Sonde Health since 2019. He previously was the chief operating officer at Quartet Health and education technology company Knewton and was a senior vice president at AOL. He earned an engineering degree from Purdue and an MBA from Columbia.
Read MoreSonde’s vocal biomarker technology to analyze ongoing mental and physical health challenges of people across four African countries during the COVID-19 pandemic
Sonde Health, in collaboration with Michigan State University, University of Botswana, University of Ghana, University of Dar es Salaam, and University of Nigeria, Nsukka, has launched a new study that uses vocal biomarkers to identify and understand the relationship among physical activity, mental health, and respiratory health of individuals living in Africa during the COVID-19 pandemic.
Read MoreBOSTON--(BUSINESS WIRE)--Sonde Health and the Cognitive Behavior Institute (CBI) have teamed up to study the effectiveness of Sonde’s Mental Fitness app as an engagement and monitoring tool for patients with depression and anxiety to help health systems and wellness service providers enhance patient care.
The study will use Sonde Mental Fitness, a voice-enabled mental health detection and monitoring technology that analyzes the sound of patients’ voices to evaluate aspects of mental well-being. By combining voice recordings, patient symptoms, and medical data, this research will enable Sonde to continue to improve its vocal biomarker models for depression and mental health monitoring.
A leader from the health tech company explains how voice-based technologies could transform monitoring of patients with dementia, Alzheimer's, and other conditions.
Vocal biomarkers can be highly useful, telling caregivers and researchers things that other vital signs are not able to fully show. Outsourcing-Pharma recently spoke with David Liu, CEO of health technology company Sonde Health, about the potential of vocal biomarkers in research and care, and how the company's voice-enabled symptom detection and monitoring platform can be useful in watching chronic and mental health conditions
Remote patient monitoring—using electronic devices to collect and record health and medical data in one location and having that data reviewed by a provider in another location—has become much more mainstream. RPM enables aging patients, individuals with chronic diseases and others to better manage their health remotely.
The Covid-19 pandemic has enhanced the use of RPM technology. But the real boom is still coming.
Read MoreImagine a test as quick and easy as having your temperature taken or your blood pressure measured that could reliably identify an anxiety disorder or predict an impending depressive relapse.
Health care providers have many tools to gauge a patient’s physical condition, yet no reliable biomarkers — objective indicators of medical states observed from outside the patient — for assessing mental health.
But some artificial intelligence researchers now believe that the sound of your voice might be the key to understanding your mental state — and A.I. is perfectly suited to detect such changes, which are difficult, if not impossible, to perceive otherwise. The result is a set of apps and online tools designed to track your mental status, as well as programs that deliver real-time mental health assessments to telehealth and call-center providers.
Read MoreLike almost every other industry, Healthcare has undergone a Digital Transformation in the past decade. Health IT standards such as Consolidated-Clinical Document Architecture (C-CDA), Integrating the Healthcare Enterprise (IHE), Fast Healthcare Interoperability Resource (FHIR), Prescription Drug Monitoring Program (PDMP) have made digital access to health data for clinicians, patients, and researchers more collaborative and safer, and along with trends such as virtual care, AI, and automation, are helping to drive innovative treatments and cures.
Read MoreBOSTON--(BUSINESS WIRE)--Sonde Health, a leading enterprise vocal biomarker company, and GN Group, a global leader in intelligent audio solutions, have signed a multi-year strategic partnership to research and develop commercial vocal biomarkers for Mild Cognitive Impairment. The research will serve as the backbone for new voice-based tools to help at-risk individuals gain timely and accurate health insights using GN Group’s device technologies and, ultimately, to enable early detection and management of life-threatening diseases for the millions of people living with hearing loss.
Read MoreBOSTON--(BUSINESS WIRE)--Sonde Health announced that it will work with leading chipmaker Qualcomm Technologies, Inc. to optimize Sonde’s vocal biomarker technology for use with the flagship and high-tier Qualcomm® Snapdragon™ 888 and 778G 5G Mobile Platforms to help bring native, machine learning-driven vocal biomarker capabilities to mobile and IoT devices globally. The optimization has the potential to unlock several native health screening and monitoring applications on hundreds of millions of mobile devices that use these Snapdragon mobile platforms.
Read MoreQualcomm has finally unveiled the new Snapdragon 8 Gen 1 mobile platform, the first chipset to adopt Qualcomm's new naming convention that it teased earlier this month. This new "simplified" naming scheme represents a new generation for Qualcomm that focuses its efforts on advanced AI processing and fast 5G speeds.
Read MoreDuring the annual Snapdragon Tech Summit 2021, Qualcomm Technologies, Inc. introduced its latest premium 5G mobile platform, Snapdragon® 8 Gen 1. The new Snapdragon 8 leads the way into a new era of premium mobile technology equipped with cutting-edge 5G, AI, gaming, camera, and Wi-Fi and Bluetooth® technologies to transform the next generation of flagship devices. Snapdragon 8 Gen 1 will be adopted by global OEMs and brands including Black Shark, Honor, iQOO, Motorola, Nubia, OnePlus, OPPO, Realme, Redmi, SHARP, Sony Corporation, vivo, Xiaomi, and ZTE, with commercial devices expected by the end of 2021.
Read MoreBelieve it or not, we’re almost two years into this pandemic, and it is taking a massive toll on America’s mental health. Recent data from the CDC found that more than 40 percent of adults in the U.S. have reported symptoms of anxiety or depression. Like any disease, these issues can have devastating consequences if they’re left untreated: An estimated 44,800 Americans lost their lives to suicide last year, making it among the leading causes of death here in the U.S..
Of course, this crisis has not been lost on the tech startup space. Popular apps like Spring Health, Ginger and Lyra Health have reeled in massive amounts of venture funding this year for their unique approaches…
Read MoreSonde is looking to use vocal biomarkers to help evaluate mental wellness with its new API called Sonde Mental Fitness.
According to the company, health systems, employers and wellness service providers are able to tap into the API as a way to gather insights about their patients. The tool uses audio signal processing and machine learning to analyze 30-second audio clips of a user’s voice and detect any vocal changes that could be a sign of mental state.
The technology is able to transcribe and store the voice sample as daily diary entries. Users can then track their moods and emotions over time. The tool also offers health tips for mental wellness.
Read MoreBOSTON--(BUSINESS WIRE)--Sonde Health has unveiled Sonde Mental Fitness, a voice-enabled mental health detection and monitoring technology that uses a brief voice sample to evaluate mental well-being. Available as an application programming interface (API) for health systems, employers, and wellness service providers, Sonde Mental Fitness is an easy and affordable way for individuals to engage with and better understand their mental well-being and can serve as a much-needed early warning system for depression and other mental health conditions.
Read More